These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32260480)

  • 1. Do Adolescents Use Substances to Relieve Uncomfortable Sensations? A Preliminary Examination of Negative Reinforcement among Adolescent Cannabis and Alcohol Users.
    May AC; Jacobus J; Stewart JL; Simmons AN; Paulus MP; Tapert SF
    Brain Sci; 2020 Apr; 10(4):. PubMed ID: 32260480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Under pressure: adolescent substance users show exaggerated neural processing of aversive interoceptive stimuli.
    Berk L; Stewart JL; May AC; Wiers RW; Davenport PW; Paulus MP; Tapert SF
    Addiction; 2015 Dec; 110(12):2025-36. PubMed ID: 26234745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What do you feel? Adolescent drug and alcohol users show altered brain response to pleasant interoceptive stimuli.
    Migliorini R; Stewart JL; May AC; Tapert SF; Paulus MP
    Drug Alcohol Depend; 2013 Dec; 133(2):661-8. PubMed ID: 24071571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex moderates effects of alcohol and cannabis co-use on alcohol and stress reactivity.
    Claus ED; Blaine SK; Witkiewitz K; Ansell EB
    Alcohol Clin Exp Res; 2022 Apr; 46(4):530-541. PubMed ID: 35229336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating a novel fMRI cannabis cue reactivity task in youth.
    Karoly HC; Schacht JP; Meredith LR; Jacobus J; Tapert SF; Gray KM; Squeglia LM
    Addict Behav; 2019 Feb; 89():20-28. PubMed ID: 30243035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofunctional changes in adolescent cannabis users with and without bipolar disorder.
    Bitter SM; Adler CM; Eliassen JC; Weber WA; Welge JA; Burciaga J; Shear PK; Strakowski SM; DelBello MP
    Addiction; 2014 Nov; 109(11):1901-9. PubMed ID: 24962329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis craving in response to alcohol cues in the laboratory and in daily life among adolescents ages 15-17 years.
    Wycoff AM; Rogers K; Parlette B; Miranda R; Treloar Padovano H
    Alcohol Clin Exp Res (Hoboken); 2023 Dec; 47(12):2366-2374. PubMed ID: 38151781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interoceptive attention in opioid and stimulant use disorder.
    Stewart JL; Khalsa SS; Kuplicki R; Puhl M; T Investigators ; Paulus MP
    Addict Biol; 2020 Nov; 25(6):e12831. PubMed ID: 31617639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescent Brain Surface Area Pre- and Post-Cannabis and Alcohol Initiation.
    Infante MA; Courtney KE; Castro N; Squeglia LM; Jacobus J
    J Stud Alcohol Drugs; 2018 Nov; 79(6):835-843. PubMed ID: 30573013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered frontocingulate activation during aversive interoceptive processing in young adults transitioning to problem stimulant use.
    Stewart JL; Parnass JM; May AC; Davenport PW; Paulus MP
    Front Syst Neurosci; 2013; 7():89. PubMed ID: 24298242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater Prevalence of Proposed ICD-11 Alcohol and Cannabis Dependence Compared to ICD-10, DSM-IV, and DSM-5 in Treated Adolescents.
    Chung T; Cornelius J; Clark D; Martin C
    Alcohol Clin Exp Res; 2017 Sep; 41(9):1584-1592. PubMed ID: 28667763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent Versus Co-occurring Substance Use in Relation to Gambling Outcomes in Older Adolescents and Young Adults.
    Cronce JM; Bittinger JN; Di Lodovico CM; Liu J
    J Adolesc Health; 2017 May; 60(5):528-533. PubMed ID: 28011065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent cortical thickness pre- and post marijuana and alcohol initiation.
    Jacobus J; Castro N; Squeglia LM; Meloy MJ; Brumback T; Huestis MA; Tapert SF
    Neurotoxicol Teratol; 2016; 57():20-29. PubMed ID: 27687470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evidence that computerized approach avoidance training is not associated with changes in fMRI cannabis cue reactivity in non-treatment-seeking adolescent cannabis users.
    Karoly HC; Schacht JP; Jacobus J; Meredith LR; Taylor CT; Tapert SF; Gray KM; Squeglia LM
    Drug Alcohol Depend; 2019 Jul; 200():145-152. PubMed ID: 31132681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent heavy drinkers' amplified brain responses to alcohol cues decrease over one month of abstinence.
    Brumback T; Squeglia LM; Jacobus J; Pulido C; Tapert SF; Brown SA
    Addict Behav; 2015 Jul; 46():45-52. PubMed ID: 25796007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural responses associated with cue-reactivity in frequent cannabis users.
    Cousijn J; Goudriaan AE; Ridderinkhof KR; van den Brink W; Veltman DJ; Wiers RW
    Addict Biol; 2013 May; 18(3):570-80. PubMed ID: 22264344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Cannabis and Alcohol Co-Use in Adolescents: A Narrative Review of the Evidence.
    Karoly HC; Ross JM; Ellingson JM; Feldstein Ewing SW
    J Dual Diagn; 2020; 16(1):58-74. PubMed ID: 31519143
    [No Abstract]   [Full Text] [Related]  

  • 18. Do you feel alright? Attenuated neural processing of aversive interoceptive stimuli in current stimulant users.
    Stewart JL; Juavinett AL; May AC; Davenport PW; Paulus MP
    Psychophysiology; 2015 Feb; 52(2):249-62. PubMed ID: 25183168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Perceived Stress, Amygdala Reactivity to Acute Psychosocial Stress, and Alcohol and Cannabis Use in Adolescents and Young Adults With Bipolar Disorder.
    Le V; Kirsch DE; Tretyak V; Weber W; Strakowski SM; Lippard ETC
    Front Psychiatry; 2021; 12():767309. PubMed ID: 34867554
    [No Abstract]   [Full Text] [Related]  

  • 20. Is recovery from cannabis use problems different from alcohol and other drugs? Results from a national probability-based sample of the United States adult population.
    Kelly JF; Greene MC; Bergman BG
    Int J Drug Policy; 2018 Mar; 53():55-64. PubMed ID: 29287223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.